Insights

2022 PTAB Annual Conference Takeaways

Choate was a sponsor of the recent PTAB Bar Association Annual Conference in Washington D.C., where more than 150 practitioners, in-house counsel, and attorneys from law firms gathered to hear the latest updates and trends.

Michael Bunis and Stephanie Schonewald participate in IP Life Sciences Executive Roundtable

Michael Bunis and Stephanie Schonewald will each participate in panel discussions at the Consero IP Life Sciences Executive Roundtable on Thursday, March 24.

Stephanie Schonewald Named on 2021 Top 50 Women in PTAB Trials List

For the second time, Choate Partner Stephanie L. Schonewald, Ph.D., has been named on the Top 50 Women in PTAB Trials list by the PTAB Bar Association’s Women’s Committee.

Dr. Stephanie Schonewald Quoted in Law360 about Patent Specification Concerns at the PTAB

Dr. Stephanie Schonewald was recently quoted in Law360 about takeaways from her IP Watchdog PTAB Masters 2022 virtual panel “Life Sciences and IPR: Orange Book & Biologic Patents at the PTAB.”

Dr. Stephanie Schonewald Examines Orange Book & Biologic Patents at the PTAB

Dr. Stephanie Schonewald will present on the IP Watchdog PTAB Masters 2022 virtual panel “Life Sciences and IPR: Orange Book & Biologic Patents at the PTAB” on Thursday, January 27.

Choate Elects Six to Partnership

Today Choate announced its largest class of new equity partners in the Firm’s history for the second year in a row.

2021 PTAB Annual Conference Takeaways

From September 22-24, 2021, Choate was a sponsor of the PTAB Bar Association Annual Conference in Washington D.C., where more than 150 practitioners, in-house counsel, and attorneys from law firms gathered to hear the latest updates and trends. Below are key takeaways from the conference.

FDA Issues Continued Guidance on Biosimilar Development and the BPCIA

The Biologics Price Competition and Innovation Act (“BPCIA”) created an abbreviated licensure pathway for biological products shown to be biosimilar to or interchangeable with an FDA-licensed biological reference product.  

Michael Bunis and Dr. Stephanie Schonewald Analyze Section 112 Enablement

Michael Bunis and Dr. Stephanie Schonewald will lead the BIO Biotech Intellectual Property Law in Focus webinar “Section 112 Enablement: What to Watch Out For” on Wednesday, September 29 at 1:00 pm EST.